Snowball logo
logo
TMAN

T Man Pharmaceutical PCL

TMAN BK
฿10.60-฿0.10  (0.93%)
Estimate
P/E
8.2
EPS
1.3
Beta
0.059
Growth
Revenue, YoY
5.99%
Net income, YoY
-5.97%
FCF, YoY
-19.88%
Forecast
P/E (FWD)
7.6
EPS (FWD)
1.39
Dividends
Dividend yield
6.04%
Annual payout
฿0.64
Next ex. div date
November 8, 26
Payout
34.11%
Div.rating
About the company
Ticker
TMAN
ISIN
Country
Thailand
Sector (GICS)
Other
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and traditional medicines, dietary supplements, vitamins and minerals, skin care and aesthetics, whey protein, and mommy and kid products, as well as cosmetics, modern medicines, mossi guard, nevtral, propolis, and vita-c products. In addition, it offers products under various brand names, such as Iyara, Propoliz, POLAR, and Fibermate. The company also exports its products. Further, the company offers original equipment manufacturing services. Additionally, it offers medicines in the form of tablets, capsules, powders, liquids, and semisolids. The company also exports its products. T.Man Pharmaceutical Public Company Limited was founded in 1991 and is based in Bangkok, Thailand.

Frequently asked questions

What sector does T Man Pharmaceutical PCL (TMAN) operate in?

T Man Pharmaceutical PCL belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is T Man Pharmaceutical PCL (TMAN) current stock price?

As of the latest data, T Man Pharmaceutical PCL stock price is THB 10.60, with a previous close of THB 10.70. T Man Pharmaceutical PCL lost -THB 0.10 in the last trading session, representing a -0.93% loss.

What is T Man Pharmaceutical PCL (TMAN) current market capitalization?

T Man Pharmaceutical PCL market cap is approximately 4.24 billion.

What is T Man Pharmaceutical PCL (TMAN) Earnings Per Share (EPS)?

The trailing EPS is THB 1.30, and the forward EPS is THB 1.39.

What is T Man Pharmaceutical PCL (TMAN) Price-to-Earnings (P/E) ratio?

T Man Pharmaceutical PCL current P/E ratio is 8.15, with a forward P/E of 7.63.

Does T Man Pharmaceutical PCL (TMAN) pay dividends?

Yes. T Man Pharmaceutical PCL pays semiannual dividends with an annualized yield of 6.04% and an estimated annual payout of THB 0.64 per share.

When is the next ex-dividend date for T Man Pharmaceutical PCL (TMAN)?

The next ex-dividend date is scheduled for November 08, 2026.

How did T Man Pharmaceutical PCL (TMAN) perform in its most recent earnings report?

In the last report (March 31, 2026), T Man Pharmaceutical PCL posted an EPS surprise of 0% and a revenue surprise of -3.7%.

What is T Man Pharmaceutical PCL (TMAN) beta (volatility) score?

T Man Pharmaceutical PCL has a beta of 0.059, indicating lower volatility than the overall market.